202 related articles for article (PubMed ID: 16711153)
1. [Blisters unlike others].
Gugerli O; Leupin N
Rev Med Suisse; 2006 Apr; 2(62):1076-7. PubMed ID: 16711153
[No Abstract] [Full Text] [Related]
2. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
3. [Hand-foot syndrome with capecitabine therapy].
Marini A; Hengge UR
Hautarzt; 2007 Jun; 58(6):532-6. PubMed ID: 16897045
[TBL] [Abstract][Full Text] [Related]
4. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
5. Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
Villalón G; Martín JM; Pinazo MI; Calduch L; Alonso V; Jordá E
Am J Clin Dermatol; 2009; 10(4):261-3. PubMed ID: 19489659
[TBL] [Abstract][Full Text] [Related]
6. Acral and palmo-plantar hyperpigmentation in a patient with disseminated hepatocellular carcinoma.
Goyal R; Chalamalasetty SB; Madan K; Paul SB; Arora R; Safaya R; Acharya SK
Indian J Gastroenterol; 2007; 26(6):292-3. PubMed ID: 18431015
[TBL] [Abstract][Full Text] [Related]
7. Painful blistered hands and feet.
Coyle C; Wenhold V
Clin J Oncol Nurs; 2001; 5(5):230-2. PubMed ID: 11899771
[TBL] [Abstract][Full Text] [Related]
8. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
9. Pyogenic granuloma-like lesions caused by capecitabine therapy.
Piqué-Duran E; Pérez-Díaz MJ; Pérez-Cejudo JA
Clin Exp Dermatol; 2008 Aug; 33(5):652-3. PubMed ID: 18616732
[No Abstract] [Full Text] [Related]
10. High frequency of hand foot syndrome with capecitabine.
Kamil M; Haron M; Yosuff N; Khalid I; Azman N
J Coll Physicians Surg Pak; 2010 Jun; 20(6):421-2. PubMed ID: 20642979
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine and hand-foot syndrome.
Saif MW
Expert Opin Drug Saf; 2011 Mar; 10(2):159-69. PubMed ID: 21174613
[TBL] [Abstract][Full Text] [Related]
12. Pyogenic granuloma-like lesions during capecitabine therapy.
Piguet V; Borradori L
Br J Dermatol; 2002 Dec; 147(6):1270-2. PubMed ID: 12452889
[No Abstract] [Full Text] [Related]
13. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
Do JE; Kim YC
Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
[TBL] [Abstract][Full Text] [Related]
14. Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.
Lee SD; Kim HJ; Hwang SJ; Kim YJ; Nam SH; Kim BS
Korean J Intern Med; 2007 Jun; 22(2):109-12. PubMed ID: 17616027
[TBL] [Abstract][Full Text] [Related]
15. A CDD polymorphism as predictor of capecitabine-induced hand-foot syndrome--letter.
Ciccolini J; Evrard A; Lacarelle B
Clin Cancer Res; 2012 Jan; 18(1):317. PubMed ID: 22215908
[No Abstract] [Full Text] [Related]
16. Lichenoid eruption induced by sotalol.
O'Brien TJ; Lyall IG; Reid SS
Australas J Dermatol; 1994; 35(2):93-4. PubMed ID: 7702497
[No Abstract] [Full Text] [Related]
17. [Management of capecitabine-induced hand-foot syndrome by local phytotherapy].
Kern E; Schmidinger M; Locker GJ; Kopp B
Wien Med Wochenschr; 2007; 157(13-14):337-42. PubMed ID: 17704983
[TBL] [Abstract][Full Text] [Related]
18. Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding.
Latif S; Fraga G; Gadzia J
J Drugs Dermatol; 2010 Mar; 9(3):268-70. PubMed ID: 20232590
[TBL] [Abstract][Full Text] [Related]
19. Subacute cutaneous lupus erythematosus induced by capecitabine.
Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
[No Abstract] [Full Text] [Related]
20. A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
Caronia D; Martin M; Sastre J; de la Torre J; García-Sáenz JA; Alonso MR; Moreno LT; Pita G; Díaz-Rubio E; Benítez J; González-Neira A
Clin Cancer Res; 2011 Apr; 17(7):2006-13. PubMed ID: 21325291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
